MARRONE BIO INNOVATIONS INC. — Revenue by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/feaba80d-7535-42d9-b0fc-84f135fcc5f2/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2021 | $44.3M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-008186 |
| FY 2020 | $38.4M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-006648 |
| FY 2019 | $29.4M | 2019-01-01 – 2019-12-31 | evidence 0001493152-20-004083 |
| FY 2018 | $21.2M | 2018-01-01 – 2018-12-31 | evidence 0001493152-19-004161 |
| FY 2017 | $18.2M | 2017-01-01 – 2017-12-31 | evidence 0001493152-19-004161 |
| FY 2016 | $13.7M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-005870 |
| FY 2015 | $9.0M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-523740 |
| FY 2014 | $7.8M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-372823 |
| FY 2013 | $7.6M | 2013-01-01 – 2013-12-31 | evidence 0001193125-15-372823 |
| FY 2012 | $6.8M | 2012-01-01 – 2012-12-31 | evidence 0001193125-14-114512 |
| FY 2011 | $5.0M | 2011-01-01 – 2011-12-31 | evidence 0001193125-14-114512 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MARRONE BIO INNOVATIONS INC. — all facts · Net Income · Operating Income